Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer. | MicrobiomeTrials← Back to trialsNCT05025514
Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.
TERMINATEDOBSERVATIONAL
Trial Details
Start: 2021-10-19Est. Completion: 2022-09-16
Enrollment target: 125 participants Locations- CHU de Nîmes, Nîmes, Gard, France
- Centre Hospitalier d'Albi, Albi, France
- CH d'Auch, Auch, France
- CH de Cahors, Cahors, France
- Clinique des Cèdres - Capio, Cornebarrieu, France
Other microbiome trials you might be interested in
Endometrial Cancer
The objective of this clinical trial is to determine if a newly-designed and FDA-cleared vaginal speculum (the Bouquet S…
Englewood, United StatesCompleted Sep 30, 2026
Smoking Cessation
The primary objectives of this study are 1) to evaluate the longer-term impact of an adjunctive, low-cost financial ince…
Oklahoma City, United StatesCompleted Feb 8, 2022
Atypical Teratoid/Rhabdoid Tumor
Embryonal Tumor With Multilayered Rosettes
Ewing Sarcoma
Diffuse Intrinsic Pontine Glioma
Osteosarcoma
Neuroblastoma
DIPG Brain Tumor
The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (…
Birmingham, United StatesEst. completion May 2033